The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Aptamer functionalized nanomaterials for biomedical applications: Recent advances and new horizons
Abstract
Abstract With the advancement of functional nanomaterials and aptamer selection technologies, aptamer functionalized nanomaterials (AFMs) open various methods to design new sensing and imaging technologies. In this perspective, several sensitivity-enhancement methods alongside a wide range of smart nanomaterials have been incorporated to construct new AFMs to use in the biomedical field. This review first introduces the conjunction strategies for synthesizing AFMs. Then, the versatile roles of nanomaterials in advanced AFMs are discussed, including optical indicators, conducting transducer, carriers, catalysts, and other functions. Representative examples of biomedical applications are reviewed with emphasis on drug delivery, bioimaging, and aptasensors. Finally, some challenges and opportunities in this emerging field are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Nishita, M., Park, S.-Y., Nishio, T., Kamizaki, K., Wang, Z., Tamada, K., Takumi, T., Hashimoto, R., Otani, H., Pazour, G. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-016-0028-x · Cited by 15,947
Double-slit photoelectron interference in strong-field ionization of the neon dimer
Kunitski, M., Eicke, N., Huber, P., Köhler, J., Zeller, S., Voigtsberger, J., Schlott, N., Henrichs, K., Sann, H., Trinter, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07882-8 · Cited by 8,162
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Aptamer-based targeted therapy
Zhu, G., & Chen, X. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.005 · Cited by 522
Ding, S., Lyu, Z., Niu, X., Zhou, Y., Liu, D., Falahati, M., Du, D., & Lin, Y. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111830 · Cited by 139
Self-citation
Cited by
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Kashyap, B. K., Singh, V. V., Solanki, M. K., Kumar, A., Ruokolainen, J., & Kesari, K. K. (2023) · ACS Omega · doi:10.1021/acsomega.2c07840 · Cited by 348
Metadata
- Authors
- Mahmoudpour, M., Ding, S., Lyu, Z., Ebrahimi, G., Du, D., Ezzati Nazhad Dolatabadi, J., Torbati, M., & Lin, Y.
- Venue
- Nano Today
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 39
- Pages
- 101177
- ISSN
- 1748-0132 (ISSN-L)
- OpenAlex
- W3162163783
- Cited by
- 177
- References
- 9
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aptamer functionalized nanomaterials for biomedical applications: Recent advances and new horizons. https://app.cochat.ai/papers/10.1016/j.nantod.2021.101177
- The paper
- Mahmoudpour, M., Ding, S., Lyu, Z., Ebrahimi, G., Du, D., Ezzati Nazhad Dolatabadi, J., Torbati, M., & Lin, Y. (2021). Aptamer functionalized nanomaterials for biomedical applications: Recent advances and new horizons. Nano Today. https://doi.org/10.1016/j.nantod.2021.101177
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
